LEXINGTON, Mass., May 20, 2019 /PRNewswire/ -- Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that positive safety ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback